There have been substantial changes in technologies and guidelines for breast,
cervical, colorectal, and lung cancer screening in recent years. Breast, cervical, and
colorectal cancer screening are well supported by evidence and guidelines, while lung
cancer screening is controversial due to the incomplete evidence on its efficacy, although
it has diffused at least to some extent into community practice and there is need for data
to better understand PCPs' knowledge and use of lung cancer screening tests. The survey
focuses on PCPs' adoption of new or rapidly-evolving screening technologies and new
screening guidelines, as well as their use of informed decision-making in discussing
cancer screening with their patients, and practice-based systems (i.e., electronic medical
records, reminders, practice profiles, financial incentives) that support and/or otherwise
influence screening activities. Survey objectives are to characterize PCPs' knowledge,
attitudes, recommendations, and practices toward use of established and emerging
technologies for breast, cervical, colorectal, and lung cancer screening. A secondary aim
is to assess differences in knowledge, attitudes, and practices according to
characteristics of the PCP, practice setting, and external environment, for each screening
type.

Investigators who adopt or adapt any items from the questionnaires are asked to cite
the National Cancer Institute, National Survey of Primary Care Physicians' Recommendations
and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, as the
source.